Lina Khan, FTC chair (Photo by Michael Brochstein/Sipa USA)(Sipa via AP Images)
June 18, 2024 02:37 PM EDTUpdated 03:35 PM
Pharma
FDA+

FTC backs plan to tar­get more patent set­tle­ments it sees as an­ti­com­pet­i­tive

Zachary Brennan

Senior Editor

The Fed­er­al Trade Com­mis­sion on Tues­day of­fered up sup­port for a pro­posed rule from the US Patent and Trade­mark Of­fice that could help reg­u­la­tors more …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

Califf, on his way out at FDA, pre­dicts agency tug-of-war be­tween Ra­maswamy and RFK Jr.

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

A service from the Financial Times